Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the full record of transactions filed by Yocca Frank. Officer active across 1 company, notably BioXcel Therapeutics, Inc.. In total, 20 reports have been published. Breakdown: 0 buy · 2 sells. Total volume traded: €1.4m. History available since 20 January 2023. The latest transaction was filed on 20 May 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Yocca Frank
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations20 total
35 sharesCommon StockSEC:0001104659-26-075300:0
17,500 sharesCommon StockSEC:0001104659-26-065841:0
6,845 shares@ US$1.0850.021% mcap0.5% of flowCommon StockSEC:0001104659-26-065841:1
33 sharesCommon StockSEC:0001104659-26-028718:0
33 sharesCommon StockSEC:0001104659-25-121300:0
33 sharesCommon StockSEC:0001104659-25-090514:0
35 sharesCommon StockSEC:0001104659-25-090514:1
4,375 sharesCommon StockSEC:0001104659-25-069702:0
33 sharesCommon StockSEC:0001104659-25-059981:0
31 sharesCommon StockSEC:0001104659-25-024532:0
521 sharesCommon StockSEC:0001104659-24-129457:0
21,250 sharesCommon StockSEC:0001104659-24-106062:0
521 sharesCommon StockSEC:0001104659-24-100752:0
521 sharesCommon StockSEC:0001104659-24-073004:0
521 sharesCommon StockSEC:0001104659-24-044857:0
521 sharesCommon StockSEC:0001104659-23-126926:0
521 sharesCommon StockSEC:0001104659-23-101641:0
521 sharesCommon StockSEC:0001104659-23-072398:0
2,084 sharesCommon StockSEC:0001104659-23-033406:0
50,000 shares@ US$30.0099.5% of flowCommon StockSEC:0001104659-23-006298:0
About Yocca Frank
Yocca Frank is an insider linked to BioXcel Therapeutics, Inc. (XNAS), where the listed role is Chief Scientific Officer. The 20 filings recorded cover, in the sampled recent filings, sales totaling EUR 1390934 between 2023-01-24 and 2026-06-17, with the transaction nature listed as option exercise.